In a recently published phase 2a trial, inhaled SB010 statistically significantly attenuated asthmatic responses after allergen challenge in patients with allergic asthma and decreased the Th2-mediated inflammatory profile including blood interleukin-5 and sputum eosinophilia [22]. Here, IL5 is linked to Increased total eosinophil count.